1. Home
  2. COEP vs RFM Comparison

COEP vs RFM Comparison

Compare COEP & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • RFM
  • Stock Information
  • Founded
  • COEP 2017
  • RFM 2020
  • Country
  • COEP United States
  • RFM United States
  • Employees
  • COEP N/A
  • RFM N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • RFM Finance/Investors Services
  • Sector
  • COEP Health Care
  • RFM Finance
  • Exchange
  • COEP Nasdaq
  • RFM Nasdaq
  • Market Cap
  • COEP 86.0M
  • RFM 88.2M
  • IPO Year
  • COEP N/A
  • RFM N/A
  • Fundamental
  • Price
  • COEP $16.71
  • RFM $14.39
  • Analyst Decision
  • COEP
  • RFM
  • Analyst Count
  • COEP 0
  • RFM 0
  • Target Price
  • COEP N/A
  • RFM N/A
  • AVG Volume (30 Days)
  • COEP 63.6K
  • RFM 20.7K
  • Earning Date
  • COEP 11-12-2025
  • RFM 01-01-0001
  • Dividend Yield
  • COEP N/A
  • RFM 9.74%
  • EPS Growth
  • COEP N/A
  • RFM N/A
  • EPS
  • COEP N/A
  • RFM N/A
  • Revenue
  • COEP $263,555.00
  • RFM N/A
  • Revenue This Year
  • COEP N/A
  • RFM N/A
  • Revenue Next Year
  • COEP N/A
  • RFM N/A
  • P/E Ratio
  • COEP N/A
  • RFM N/A
  • Revenue Growth
  • COEP N/A
  • RFM N/A
  • 52 Week Low
  • COEP $2.31
  • RFM $12.89
  • 52 Week High
  • COEP $19.19
  • RFM $16.41
  • Technical
  • Relative Strength Index (RSI)
  • COEP 58.33
  • RFM 57.77
  • Support Level
  • COEP $16.00
  • RFM $14.27
  • Resistance Level
  • COEP $18.15
  • RFM $14.50
  • Average True Range (ATR)
  • COEP 1.60
  • RFM 0.11
  • MACD
  • COEP 0.05
  • RFM -0.01
  • Stochastic Oscillator
  • COEP 61.02
  • RFM 60.36

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: